Instruction for Sialor Rhino
Reed more and buy Sialor Rhino here
Release form, composition and packaging
Sialor Rhino is made in the form of a liquid that contains the active ingredient - oxymetazoline hydrochloride in an amount of 0.5 mg. Fillers:
disodium salt of ethylenediaminetetraacetic acid;
antiseptic, antifungal drug - benzalkonium chloride;
food additive E339 as a regulator of acidity, emulsifier, stabilizer, water-retaining component;
The substance is transparent in appearance, without color and odor. Photo Sialor Rhino posted on the Internet. The solution for the common cold is contained in tubes with a dropper already ready for use. Vials of different capacities are available - for 2, 10, 15 and 20 ml. Stacked in packs of cardboard. The price of Sialor Rhino depends on the volume of the product.
The medication is used for local use. It has a vasoconstrictor effect. After intranasal administration, edema of the pituitary surface of the upper respiratory passages is eliminated. When instilled into the eyes, irritation of the conjunctival sac decreases. The main ingredient of the drug is oxymetazoline, which is included in the group of alpha-adrenoactivators. As a result of its action, breathing through the nose becomes normal, since the openings of the paranasal sinuses — the airways in the skull — are freed from puffiness. The medication begins its work 5 minutes after the procedure in the nasal passage. The pharmacological result is stable for 8-12 hours. Nasal material does not enter the systemic circulation. After its introduction, the pituitary membrane retains moisture, and there are no discomfort in the form of burning or itching.
Drops are prescribed for the treatment of acute colds of the upper respiratory tract, which is accompanied by a runny nose:
allergenic inflammation of the pituitary surface;
violation of the vascular tone of the mucosa;
lack of drainage during irritation of the accessory chambers, middle ear, inflammation of the mucous membrane of the auditory (Eustachian) tube and tympanic cavity.
The nasal product is prescribed before diagnostic procedures in order to clean the channels of mucus and relieve swelling, stagnation.
Sialor Rhino is forbidden to appoint with:
hypersensitivity to the components of the drug;
sluggish cardiac dysfunction;
the pathogenic state of the thyroid gland, accompanied by increased synthesis of thyroid hormones;
irritation of the pituitary surface of the nose without the formation of mucus;
diabetes mellitus syndrome;
increased heart rate;
high blood pressure;
acute or chronic closure of the anterior corner of the visual organ;
Sialor Rhino is contraindicated in the case of parallel intake of MAO blockers before the start of treatment and after it for 14 days. A child under one year old is not prescribed a 0.025% drop, up to 6 years old - a 0.05% drop.
Dosage and administration
The drug is administered intranasally. The doctor determines the dosage based on the age of the patient. The standard dose is 1-2 drops in each nostril 2-3 times a day. For babies up to 4 weeks, a solution of a concentration of 0.01% is indicated for use. The course of treatment lasts no longer than one week. If the frequency and duration of use increases, then the phenomenon of nasal congestion increases and becomes reversible. Delivery of goods Sialor Rhino in Moscow is carried out during the working day.
Pregnancy and lactation
Oxymethazoline during the period of gestation and feeding the newborn with breast lactose is prohibited.
Side effects of Sialor Rhino
In case of violation of the treatment regimen, reactive redness of the nasal mucosa and its atrophy appear. Accidental phenomena against the background of the introduction of the drug arise from:
respiratory organs - reversible dryness of the pituitary surface, burning, dryness in the oral cavity, larynx;
heart and blood vessels - a feeling of palpitations, increased blood pressure;
central nervous organization - irritability, dizziness, insomnia;
gastrointestinal tract - symptoms of nausea;
visual perception - the lack of reaction of the pupil to light, impaired accommodation, inflammation of the conjunctiva, abnormal position of the eyelids.
The preservative in Sialor Rhino - benzalkonium chloride - causes swelling of the pituitary surface. If this happens, then the pharmaceutical substance is canceled.
When used in combination with monoamine oxidase blockers and tricyclic antidepressants, blood pressure rises. According to reviews, Sialor Rhino inhibits the absorption of local painkillers and prolongs their effect. Concurrent use with other vasoconstrictors increases the likelihood of complications.
At the time of instillation of the medicine, one should be careful that it does not get into the eyes. To exclude infection of surrounding people, each patient should have an individual dropper. After uncorking the container, the substance can be used for no more than two weeks. If there is a violation of the vestibular apparatus after the procedures, the patient is prohibited from independently managing transport mechanisms and engaging in hazardous activities. Chemical product in the form of an ophthalmic solution is contraindicated in children under 6 years of age. If the patient is diagnosed with chronic renal dysfunction, then the use of Sialor Rhino is prohibited.
Terms and conditions of storage
The solution must be stored at a temperature of no higher than + 25 ° C. Shelf life in closed form is not more than 2 years.
Terms of sell
You don't need a prescription to buy Sialor Rhino.